Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
33.4 USD | +11.48% | +9.11% | +72.34% |
Apr. 29 | Leerink Partners Starts Neurogene With Outperform Rating, $46 Price Target | MT |
Mar. 22 | North American Morning Briefing : Stocks Struggle After New Records | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+72.34% | 385M | |
+1.77% | 42.75B | |
+47.70% | 41.61B | |
+12.24% | 41.34B | |
-8.83% | 26.59B | |
+7.44% | 25.49B | |
-23.01% | 18.12B | |
+30.56% | 12.24B | |
-1.82% | 11.76B | |
+8.35% | 11B |
- Stock Market
- Equities
- NGNE Stock
- News Neurogene Inc.
- Neoleukin Therapeutics Board Approves 1-for-5 Reverse Stock Split